BioSpace News Archive

Business

Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update

Selecta Biosciences, Inc. today announced that it plans to host a conference call on Thursday, August 4, 2022, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2022 and provide a business update.

July 28, 2022
·
1 min read
Business

Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

Xtant Medical Holdings, Inc. today announced that it will release its financial results for the second quarter ended June 30, 2022, before the open of the financial markets on Thursday, August 4, 2022.

July 28, 2022
·
1 min read
Business

AGC Biologics Supports Altheia Science’s Gene Therapy ProgramsThe CDMO’s Milan facility provides lentiviral vector and autologous CD34+ cell-based drug products for clinical testing

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Altheia Science, a gene therapy company pioneering cell and gene therapy strategies to treat autoimmune diseases and cancer.

July 28, 2022
·
3 min read
Business

Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

Caladrius Biosciences, Inc. today announced that the Company will report its financial results for the three and six months ended June 30, 2022, on Thursday, August 4, 2022, at 4:30 p.m. (EDT).

July 28, 2022
·
2 min read
Business

Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Vallon Pharmaceuticals, Inc. today reported its financial results for the quarter ended June 30, 2022 and provided a corporate update.

July 28, 2022
·
5 min read
Business

Integer Holdings Corporation Reports Second Quarter 2022 Results

Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three months ended July 1, 2022.

July 28, 2022
·
26 min read
Business

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2022 financial results after the market close on Thursday, August 11, 2022.

July 28, 2022
·
1 min read
Drug Development

Akari Therapeutics Announces Positive Results from Recent Pre-Clinical Studies of Investigational PASylated® Nomacopan That Support the Potential to Advance Research Toward IND/IMPD for Clinical Trials in Geographic Atrophy

Akari Therapeutics, Plc today announced positive results from recent pre-clinical studies on the tolerability and extended dose interval of long-acting PAS-nomacopan in development for geographic atrophy (GA) in dry age-related macular degeneration (dAMD).

July 28, 2022
·
10 min read
Biotech Bay

GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal Antibodies

GigaGen Inc. announced today the publication of a research article titled, “GMP manufacturing and IND-enabling studies of a recombinant hyperimmune globulin targeting SARS-CoV-2,” in the international, peer-reviewed journal Pathogens.

July 28, 2022
·
5 min read
Business

Sight Sciences to Report Second Quarter 2022 Financial Results on August 11, 2022

Sight Sciences, Inc today announced it will report financial results for the second quarter ended June 30, 2022, after the market close on Thursday, August 11, 2022.

July 28, 2022
·
1 min read